New research on a widely used sleeping aid has raised concerns among scientists regarding its extended use. An analysis involving over 130,000 adults with insomnia from various countries suggests a link between long-term melatonin prescription and increased heart risks.
These results, which have not yet undergone peer review, do not alter current health guidelines and do not prove that melatonin causes heart problems. Melatonin remains the fourth most popular natural product among US adults, typically regarded as safe for short-term use.
Melatonin is generally safe and well-tolerated for short-term use in those who are not pregnant or breastfeeding, usually for 1 to 2 months.
Limited research exists on the effects of melatonin beyond this period, prompting calls from some experts for further studies as its use continues to rise.
The findings were presented recently at the American Heart Association's Scientific Sessions.
This preliminary research highlights the need to carefully investigate melatonin's safety in long-term use, despite its accepted short-term safety profile.